|
MARCH5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71718195218773E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77369230414115E-12 |
| Normal-vs-Stage2 |
1.71569999996013E-06 |
| Normal-vs-Stage3 |
5.5869000004094E-07 |
| Normal-vs-Stage4 |
1.754030E-04 |
| Stage1-vs-Stage2 |
3.210000E-01 |
| Stage1-vs-Stage3 |
6.104200E-01 |
| Stage1-vs-Stage4 |
3.795000E-01 |
| Stage2-vs-Stage3 |
6.875600E-01 |
| Stage2-vs-Stage4 |
9.099200E-01 |
| Stage3-vs-Stage4 |
6.717400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62803104331033E-12 |
| Normal-vs-AfricanAmerican |
9.03139996122349E-09 |
| Normal-vs-Asian |
8.792300E-02 |
| Caucasian-vs-AfricanAmerican |
8.740400E-02 |
| Caucasian-vs-Asian |
5.900600E-01 |
| AfricanAmerican-vs-Asian |
9.460000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.19129999999845E-05 |
| Male-vs-Female |
1.56090000003051E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.04050001947797E-09 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
1.13499998288802E-09 |
| Normal-vs-Extreme_Obese |
1.495630E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.881800E-02 |
| Normal_Weight-vs-Obese |
5.211000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.556400E-01 |
| Extreme_Weight-vs-Obese |
7.796100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.318200E-01 |
| Obese-vs-Extreme_Obese |
8.663200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.419800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.94839757847876E-14 |
| Normal-vs-Age(61-80Yrs) |
1.40998324127395E-13 |
| Normal-vs-Age(81-100Yrs) |
6.35229979728535E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.270970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.086100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.424180E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.385200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.253800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.399600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
1.83909554252182E-11 |
| Normal-VS-KIRP CIMP |
4.949200E-01 |
| Normal-VS-Unclassified PRCC |
2.82220025127344E-10 |
| Type1 PRCC-VS-Type2 PRCC |
7.529600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.135600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.902000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.979980E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.056000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.457800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.56141807553468E-14 |
| Normal-vs-N1 |
9.771700E-04 |
| Normal-vs-N2 |
8.42430000000949E-05 |
| N0-vs-N1 |
2.903800E-02 |
| N0-vs-N2 |
4.512600E-01 |
| N1-vs-N2 |
1.518190E-01 |
|
|
